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Hyposalivation because of curative radiation therapy in patients with 
head and neck cancer is a major concern. At present, there is no 
effective treatment for hyposalivation, highlighting the importance of 
cell therapy as a new therapeutic approach. To provide functional cells 
for cell replacement therapy, it is important to overcome the limitations 
of current in vitro culture methods for isolated salivary gland cells. 
Here, an improved culture condition method for the cultivation of 
isolated salivary gland cells was suggested in this study. The 
dissociated submandibular salivary gland cells of mice were seeded and 
treated with Rho-associated kinase (ROCK) inhibitor (Y-27632), which 
resulted in an increase in their cell adhesion, viability, migration, and 
proliferation. In particular, ROCK inhibitor (ROCKi) treatment 
maintained the expression of α-amylase in the primary cultured salivary 
gland cells for a long time as compared with untreated cells. The 
expression of C-Met, a ductal cell marker, was increased in cells 
treated with ROCKi. This modified culture condition may serve as an 
easy and convenient tool for culturing primary salivary gland cells for 
their application in hyposalivation therapy.
Key words : ROCK inhibitor, Y-27632, Hyposalivation, Submandibular 
salivary gland, Ductal cells, Primary cell culture
Student Number : 2012-31192
Contents
List of figures i
1. Introduction 1 
2. Review of literature 3  
3. Materials and Methods 28
  3.1. Preparation of primary submandibular salivary gland cells from 
mouse and in vitro culture 28
  3.2. Measurement of the anti-apoptotic effect of Y-27632 on 
submandibular salivary gland cells 29
  3.3. Cell proliferation assay 29 
  3.4. In vitro live-dead assay 30
  3.5. In vitro scratch assay 30
  3.6. Immunofluorescence staining 31
  3.7. Western blotting 32
  3.8. Statistical analysis 33
4. Results 34
  4.1. ROCK inhibitor treatment enhances the growth and survival of 
isolated submandibular gland cells 34
  4.2. ROCK inhibition increases the proliferation of salivary gland 
cells 35
  4.3.  ROCK inhibition increases the motility of salivary gland cells 
       36






Figure 1. Survival and growth of salivary gland cells by ROCKi.
42
Figure  2. Proliferation of salivary gland cells by ROCKi.44
Figure  3. Migration of salivary gland cells by ROCKi.46





Hyposalivation is the most predictable side-effect of radiation therapy 
in patients with head and neck cancer, attributable to the irreversible 
damage caused to salivary glands. Prolonged reduction in the saliva by 
hyposalivation may cause several problems, including xerostomia, 
halitosis, dental caries, mucosal infections, burning mouth syndrome, 
and dysphagia (Vissink A and Burlage FR, 2003; Vissink A and 
Jansma J, 2003). Although several patients undergoing irradiation 
therapy exhibit hyposalivation or salivary gland atrophy, there are no 
satisfactory treatments to combat these issues. Therefore, clinical and 
experimental approaches that may replace or regenerate the impaired 
salivary gland tissue are desirable (Aframian DJ and Palmon A, 2008; 
Jensen DH et al., 2014). The application of primary cultured salivary 
gland cells in regenerative medicines for hyposalivation treatment 
requires modifications in the current cell culture conditions, as acinar 
cells that produce and secrete saliva in the salivary gland are rapidly 
degenerated and lose their secretory functions during the first 24-48 h 
in vitro cultures (Wigley CB and Franks LM, 1976). Although several 
reports show that the modulation of the extra-cellular matrix or basal 
membrane gel may improve the culture conditions and functional 
properties of isolated salivary gland cells in vitro (Oliver C, 1987; 
Durban EM, 1990; Fujita-Yoshigaki J, 2005; Maria OM, 2011), 
isolation and culture of salivary gland epithelial cells is still difficult.
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The enzyme Rho-associated kinase (ROCK) mediates various important 
cellular functions such as cell shape, viability, secretion, proliferation, 
and gene expression (Liao JK et al., 2007). Modulation of ROCK 
expression in cultures affects the cellular functions of various cell 
types. ROCK inhibition suppresses proliferation and down-regulates 
migration of vascular smooth muscle cells (Kiian I et al., 2003; 
Loirand G et al., 2006). On the other hand, a ROCK inhibitor 
(ROCKi) has been shown to remarkably improve the proliferation and 
migration of osteoblasts on hydrophobic surfaces (Tian YS et al., 2009; 
Yang S et al., 2011). In human embryonic stem cells (hESCs), ROCK 
inhibition resulted in anti-apoptotic effects and treatment with the 
ROCKi significantly increased the survival rate of hESCs (Watanabe K 
et al., 2007). In osteoblastic cells, ROCK inhibition may reverse the 
common problems of osteoblast culture, including those related with 
low adhesion, proliferation, and migration of osteoblasts on hydrophobic 
surfaces (Tian YS et al., 2009). Furthermore, ROCK inhibition 
significantly enhances the migration of human corneal endothelial cells 
but fails to induce proliferation of human corneal endothelial cells 
(Pipparelli A et al., 2013). As seen in various reports, the modulation 
of ROCK activity showed various effects on cell cultures; however, the 
effect of ROCK modulation on salivary gland cells is still unknown. 
Therefore, in this study, the effects of ROCKi on the survival, 
proliferation, migration, and functions of primary cultured salivary 
gland cells were evaluated. 
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2. Review of Literature
2.1 Overview of Salivary gland
2.1.1 salivary gland structure 
The saliva exists in the whole oral cavity in order to cover the teeth 
and oral mucosa by secreting from the three parts of major salivary 
glands, the parotid, submandibular, and sublingual glands, and from 
minor salivary glands spread throughout labial, buccal, palatal, 
retromolar and lingual regions (Nauntofte B et al., 1999). It has 
multiple functions, including the protection of teeth and oropharyngeal 
mucosa, articulation of speech, mastication, swallowing, digestion of 
foods, and maintenance of a balanced microbiota (Pedersen AM et al., 
2002; de Almeida Pdel V et al., 2008; Ekström J et al., 2011; 
Pedersen AML et al., 2012; Ekström J et al., 2012; Ligtenberg AJM et 
al., 2014, Marsh PD et al., 2016; Kilian M et al., 2016). 
The salivary glands harbor parenchymal and stromal components. The 
parenchymal compartment is consisted of acini (secretory end pieces), 
which secrete the primary saliva, connected to ductal system 
(intercalated, striated, and excretory) of salivary glands. The produced 
saliva is modified in the ductal system. Each acinus contains either 
serous or mucous cells, or mucous cells capped by serous demilunes 
(only found in the submandibular gland), arranged around the central 
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lumen. The salivary glands are histologically classified according to 
their structural composition and secretions (Young JA et al., 1987; 
Edgar WM et al., 1992; Garrett JR et al., 1998; Anderson LC et al., 
1999; Humphries SP et al., 2001; Proctor GB et al., 2007). The 
diameter and the length of the ductal system vary  depending on the  
type of glands. The major salivary glands have long and branched 
ducts, whereas  the parotid and submandibular glands contain all ductal 
systems (intercalated, striated and excretory). On the other hand, the 
sublingual and minor glands lack striated ducts (Hand AR et al., 
2008). Myoepithelial cells are stellate-shaped and contractile cells that 
surround the acini and intercalated ducts variably in the different 
glands. They are located between the basal lamina and the cytoplasmic 
membrane of acinar or ductal cells. The connective tissue that 
surrounds the major salivary glands forms septa, which divide the 
gland into lobes and lobules. These septa contain large blood vessels, 
nerves and ducts. The acini, intercalated ducts, striated ducts, small 
blood vessels and nerve cells are located within the lobules. In the 
minor salivary glands, the connective tissue merges imperceptibly with 
the surrounding connective tissue. The parenchyma has a rich supply of 
blood vessels that can form a capillary plexus, particularly adjacent to 
the ducts (Garrett JR et al., 1979). 
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2.1.2 Salivary gland secretion factors 
The function of salivary gland is under the control of various factors 
and stimuli, which can change the volume, flow, and composition of 
saliva in general. It is suggested that normal salivary secretion is 
influenced by circadian clock mechanism, which may play a role in 
different salivary gland pathologies as well (Papagerakis S et al., 
2014). The level of hydration in the body also affects salivary 
secretion. Previous report showed that the flow rates of parotid saliva 
significantly decreased in both young and old healthy adults after a 24 
h-period of fasting fluid and food (Ship JA et al., 1997), and 
conditions of acute dehydration are also related to the reduction of 
salivary flow rates (Walsh NP et al., 2004; Fortes MB et al., 2012). 
Gland size is another factor associated with saliva flow rates (Ericson 
S et al.,  1971; Inoue H et al., 2006). With regard to ageing, 
numerous studies have investigated whether the ageing is associated 
with decreasing  salivary flow rates, since both major and minor 
salivary glands undergo age-related structural anddegenerative changes, 
such as loss of secretory acini and stromal alterations.
2.1.3 Function of salivary gland
Saliva has multiple pivotal functions for the maintenance of oral health. 
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It lubricates and cleanses the teeth and oral mucosa, and it maintains 
neutral pH through its buffering capacity. The saliva also prevents 
tooth demineralization, exerts antimicrobial actions, and aids in taste 
and bolus formation. Furthermore, the saliva initiates enzymatic 
digestion of starch as well as the saliva is imperative for mastication 
and swallowing and articulation of speech (Pedersen AM et al., 2002; 
de Almeida Pdel V et al., 2008; Ekström J et al., 2011; Pedersen 
AML et al., 2012; Ekström J et al., 2012; Ligtenberg AJM et al., 
2014, Marsh PD et al., 2016). It also plays a pivotal role in the 
formation of the acquired enamel pellicle and the mucosal pellicle, 
which have a protective function that determines the initial adhesion 
and colonization of microorganisms and the composition of the resident 
oral microbiota (Kilian M et al., 2016).
2.1.4 Dysfunction of salivary gland
Dysfunction of salivary gland is any quantitative and/or qualitative 
defects in the output of saliva. It also can be a reduction in salivary 
secretion (hypofunction) or an increase in salivary secretion 
(hyperfunction). The latter, called sialorrhea (drooling or excessive 
salivation) is a relatively uncommon symptom in adults (Potulska A et 
al., 2005). Salivary gland dysfunction is often associated with 
xerostomia, which is a persistent sensation of dry mouth. Generally, 
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xerostomia occurs when the unstimulated whole saliva flow rate falls 
by 40-50% of its normal value in patients, indicating that more than 
one major salivary gland must be affected in the patients (Dawes C et 
al., 1987). However, the xerostomia may also occur without any 
evidence of salivary gland hypofunction (Fox PC et al., 1987). Thus, it 
may be a result from changes in salivary composition or function, 
particularly in lubricating mucins. Xerostomia is a common disease that 
affects at least 10% of an adult population (Thomson WM et al., 
2006; Sreebny LM et al., 2010). In general, women and older people 
show lower salivary flow rates than in men and younger people, and 
they result in a higher prevalence of xerostomia than in men and 
younger people (Locker D et al., 1993; Nederfors T et al., 1997; Astor 
FC et al., 1999; Smidt D et al., 2011; Villa A et al., 2015). 
Regardless of the etiology, patients with hyposalivation frequently 
complain of dryness in oral cavty during the daytime. Persistent and 
severe hyposalivation commonly cause mucosal changes, and then these 
changes increase  activities of caries with the lesion site on cervical, 
incisal and cuspal tooth surfaces as well as oral fungal infections 
(Edgar WM et al., 1992; Nauntofte B et al., 1999; Rudney JD et al., 
2000; Pedersen AML et al., 2005; Fox PC et al., 2008; Pedersen AML 
et al., 2012; Villa A et al., 2015; Lynge Pedersen AM et al., 2015). 
Disturbed taste sensation, impaired lubrication and dysphagia may lead 
to changes in behavior like avoiding certain foods. Gradually, changes 
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in dietary intake possibly result in nutrient deficiency and atrophy of 
the masticatory muscles, and then decreased masticatory ability 
(Loesche WJ et al., 1995; Jensen SB et al., 2003; Bardow A et al., 
2000; Dusek M et al., 1996). Consequently, salivary gland 
hypofunction and its related symptoms and clinical consequences 
frequently have negative effects on social quality of life (Pedersen AM 
et al., 1999; Gerdin EW et al., 2005; Enoki K et al., 2014).
2.1.5 Causes of hyposalivation
Intake of medications, especially of antidepressants, anxiolytics, opiates, 
antihypertensives, diuretics and antihistamines, is the most common 
reason that leads to salivary gland hypofunction and xerostomia. 
Medications can affect the salivary secretory mechanisms in various 
ways. The adverse effects of medication on salivary secretion are 
reversible and salivary gland function will usually be able to recover 
after withdrawal of the pharmacotherapy (Aliko A et al., 2015; Villa A 
et al., 2016). 
Various diseases and medical conditions also can cause salivary gland 
dysfunction, including hypofunction and alteration of salivary 
composition. Some systemic diseases like Sjögren's syndrome, 
granulomatous diseases, graft-versus-host disease, cystic fibrosis, human 
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immunodeficiency virus infection, thyroid disease, late-stage liver 
disease, and uncontrolled diabetes permanently affect the salivary gland 
tissue and function, while salivary gland infections, sialoliths, 
dehydration, depression and anxiety have transiently and negatively 
affect  salivary functions. Furthermore, hormonal disturbances, 
inflammatory gastrointestinal diseases, and malnutrition can also 
indirectly affect salivary secretion, (vonBültzingslöwen I et al., 2007; 
Jensen SB et al., 2010; Pedersen AML, 2015). 
Radiotherapy to the head and neck region of patients harboring cancer 
commonly causes xerostomia and hyposalivation. In this case, the 
development of hyposalivation depends on the accumulative dose of 
radiation and the affected volume of salivary gland from the radiation. 
Although the turnover rate of the salivary gland tissue into disease 
status is slow (approx. 60 days), salivary dysfunction already occurs 
within the first week of radiation treatment, and the salivary secretion 
is continuously decreasing during 1-3 months after radiation therapy. 
Treatment of high doses (over 60 Gray (Gy)) usually results in 
irreversible salivary gland hypofunction and xerostomia, while the 
damage from mild doses (range from 30 to 50 Gy) may be reversible 
(Jensen SB et al., 2010). Specifically, radiotherapy  directly damages 
the acinar cells, and the initial damage is mainly in the serous acini, 
but also can affect the surrounding blood vessels and nerve cells. 
However, the propagation of xerostomia in patients receiving 
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chemotherapy may usually restore the damage within 6 months to 1 
year after treatment, and then more than the half of the patients shows 
normal salivary gland. Thus, it is not clear whether combinational 
therapy with radiotherapy and chemotherapy affects the risk on the 
development of salivary disease. 
2.1.6 Current treatment of hyposalivation
Currently, there are several therapeutic strategies for treating patients of 
hyposalivation from different causes, however, the strategies are still 
not strong enough to recommend a particular treatment, either 
pharmacological or not. Several treatments used in patients with 
xerostomia temporarily improve their symptoms, in terms of some 
extent, salivary flow, but without medium or long term control in all 
cases. When the hyposalivation is caused by a irradiation of the 
parenchyma, pilocarpine is the most-prescribed parasympathomimetic 
medicine for the patients with the best results with topical and 
localized treatment (Taweechaisupapong S et al., 2006; Kim JH et al., 
2014). In clinical trials, bethanechol and cevimeline have also been 
reported the successful improvements on the levels of salivary flow 
and symptoms in irradiated patient (Jham BC et al., 2007; Leung KC 
et al., 2008). On the other hand, recently emerging biological therapies 
have not produced satisfactory results for Sjögren’s syndrome. For 
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example, rituximab, a monoclonal antibody with proven its efficacy in 
aslymphoma or rheumatoid arthritis, has not always resulted the better 
efficacy than that of placebo (Devauchelle-Pensec V et al., 2007). 
Furthermore, the use of malic acid with fluoride and xylitol, both 
spray and tablets, just relieves the symptoms of the patients (da Silva 
Marques DN et al., 2011; Gómez-Moreno G et al., 2013). 
The use of alternative stimulating agents including oral 
electro-stimulation and acupuncture could be another good therapeutic 
option for the treatment of xerostomia and hyposalivation, because 
these alternative therapy have no side effects in most cases (Strietzel 
FP et al., 2011; Simcock R et al., 2013). On the contrary, several 
trials including intraoral devices for storing artificial saliva,  mouthwash 
with triclosan, iron administration, oral supplementation with omega-3 
and vitamin E have shown ineffective (Robinson PG et al., 2005; 
Singh M et al., 2010; Saleh J et al., 2015). In short, application of 
pilocarpine, a sialogogue drug, to the patients has been resulted the 
best efficacies in patients with irradiation-induced xerostomia and 
Sjogren’s syndrome. In patients suffering from drug-related dry mouth, 
the use of malic acid along with other elements results some positive 
evidence in terms of the efficacy, but these treatment counteract the 
harmful effects on dental enamel. In general, the lubrication of the oral 
mucosa including mouth rinse with artificial saliva reduces symptoms, 
even though the effects are short-lived until now (Gil-Montoya JA et 
12
al., 2016).
2.2 Cell transplantation for therapeutic approaches
2.2.1 Existence of salivary gland stem cells 
The salivary glands are exocrine organs that produces and secretes 
saliva. Ductal ligation of rat submandibular salivary glands led to 
degeneration of saliva, but saliva flow rate returned to normal levels 
and acinar cells were reborn after deligation, suggesting the remarkable 
regenerative capacity of the salivary gland (Osailan SM et al., 2006; 
Cotroneo E et al., 2010). The salivary glands of rodents and human 
are basically composed of two saliva-producing cells (mucous and 
serous acinar cells), myoepithelial cells that facilitate saliva expulsion. 
Another compartment, a ductal system,  modifies saliva composition 
and secretes the saliva into the oral cavity. The whole union of cells 
is keeping in close physical proximity to each other by supportive  
tissues (Pavlov IP et al., 1906; Proctor GB et al., 2007). The impact 
of radiation therapy on function of salivary glands is critical. Radiation 
therapy of the salivary gland induces severe early loss (phases 1 and 
2, 0–10 days and 10–60 days after irradiation, respectively) in saliva 
production, suggesting that the salivary gland is radiosensitive (Coppes 
RP et al., 2001). The later phases of radiation-induced hyposalivation 
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(phases 3 and 4, from 60 to 120 and 120 to 240 days after 
irradiation, respectively), where in functionally mature acinar cells 
become senescence,  the cells are not replenished anymore. This 
suggests that the radiation-induced sterilization of a salivary gland 
stem/progenitor cell population in the salivary glands. 
Stem or progenitor cells have capacities of self-renewal and 
differentiation to replenish damaged cells in our body. Because the 
presence of stem cells have been identified in many tissues including 
human organs, the number of remaining undamaged salivary gland stem 
or progenitor cells will determine the regenerative capacity of the gland 
after irradiation. In fact, compensatory responses of damaged tissue in 
non-irradiated regions (presumable site for salivary gland 
stem/progenitor cells) have been demonstrated after radiation, indicating 
the potential of surviving salivary gland stem or progenitor cells to 
regenerate the tissue.
2.2.2 Marker expression of stem cell in salivary gland
Genetic labeling studies demonstrated that salivary gland stem cells 
with slow turnover capacity are located in the duct and able to 
regenerate the different cell types in the rat salivary gland (Denny PC 
et al., 2005). Branching morphogenesis study identified the salivary 
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gland stem cells that expressed keratin (KRT), which are dependent on 
nerve stimulation for their growth and survival (Knox SM et al., 
2010). Lineage tracing studies using KRT5 promoter revealed that the 
cells expressing both KRT5 and KRT14 in the developing oral 
epithelium were able to contribute to acinar, ductal, and myoepithelial 
cells in the salivary gland (Lombaert IM et al., 2008). Additional two 
other KRTs, KRT15 and KRT19 have also been suggested as markers 
of stem cells in the salivary gland. KRT15 is expressed, together with 
KRT5, in the duct of the developing salivary gland (Knox SM et al., 
2010). The expression of KRT19 is confined to the developing ducts 
and depletion of KRT19 in mice resulted in abnormal morphogenesis 
of the duct in the developing salivary gland (Nedvetsky PI et al., 
2014). These studies suggests that cells expressing KRT19 are key 
players for efficient ductal development in the salivary gland.  
Multiple receptor families of different growth factors have been 
suggested as a marker of stem cells in the salivary gland. A receptor 
tyrosine kinase, KIT was first identified as a major marker of 
hematopoietic stem cells and found to be expressed in a subset of 
KRT14+ salivary gland stem cells (Lombaert IM et al., 2013). 
Although the expression pattern of KIT is similar to that of KRT14, a 
subset of KIT+ cells do not express KRT14 in pre-acinar cells, 
suggesting distinct populations of progenitors exist in the salivary 
gland. Other markers of salivary gland stem cells  are leucine-rich 
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repeat containing G protein-coupled receptors (LGRs). They are 
components of the WNT signaling pathway. Similar to KRT5, LGR5 is 
expressed mainly in the primary duct of the developing salivary gland 
and also expressed in multipotent salivary gland mesenchymal stem 
cells (Lu L et al., 2015).   
A panel of transcription factors are thought to be involved in the 
regeneration and stem cells of the salivary gland. ASCL3 (also referred 
as Salivary Glands 1, Sgn1) is prominently expressed in excretory duct 
cells in the adult mouse salivary gland (Yoshida, S et al., 2001). The 
expression of Ascl3 (begins at E14) is also observed in the ductal 
regions of the developing salivary gland, where salivary gland stem 
cells reside, and ASCL3+ cells is able to differentiate into ductal and 
acinar cells during development (Bullard T et al., 2008). SOX2 is 
expressed throughout the oral epithelium and has a critical role in the 
generation of acini, and lack of Sox2 expression before gland 
ontogenesis perturbed the generation of Sox10+ acinar cells (Emmerson, 
E et al., 2018). Furthermore, ablation of Sox9 under the control of the 
Krt14 promoter inhibited acinar morphogenesis and impaired 
specification of distal putative progenitors, suggesting an essential role 
of Sox9 in morphogenic processes and cell fate in the salivary gland 
(Chang D et al., 2013). Transformation-related protein 63 (Trp63/P63) 
is also postulated as a marker for the salivary gland. The expression of 
p63 isoform was observed in basal epithelial and myoepithelial cells in 
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the salivary gland (Bilal H et al., 2003), and ablation of p63 caused 
depletion of all squamous epithelia and their derivatives, including the 
salivary glands (Yang A et al., 1999).
2.2.3 Clinical applications for salivary gland by stem cells
Based on markers described above, a number of studies have attempted 
to isolate salivary gland stem cells from human salivary gland for 
clinical application (Emmerson E et al., 2018). Feng et al. were able 
to generate human salispheres that expressed KIT by optimizing culture 
conditions used for murine salivary cells (Feng J et al., 2009). The 
human salivary gland-derived salispheres were able to produce multiple 
branches under 3D culture conditions with matrix (Okumura et al., 
2008). A different study demonstrated that without marker-based cell 
sorting, adherent cells in cultures of the salivary gland tissues showed 
properties of mesenchymal stem cells (MSCs), and reconstructed acinar 
tissues, and alleviated hyposalivation in irradiated animals (Jeong J et 
al., 2013). Furthermore, other studies enriched for salivary gland stem 
cells by using clonal expansion and showed that the enriched 
population had multipotency of the salivary gland stem cells (Rotter N 
et al., 2008). However, more detailed characterization for the salivary 
gland stem cells obtained from different sources and different methods 
as well as careful evaluation of therapeutic efficacy upon 
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transplantation should be followed for safe and efficient clinical 
application in the treatment of hyposalivation.
Moreover, partial salivary gland loss-of-function can within certain 
situations be spontaneously recovered post intensity-modulated radiation 
therapy (IMRT) in certain situations (Li Y et al., 2007). This lead to 
the hypothesis that endogenous salivary gland cells can participate in 
organ repair, and thus that cell transplants could potentially be 
beneficial in regeneration of severe loss of function. 
Many studies serve to emphasize the importance of a functional 
residual salivary gland stem or progenitor cell population in the 
salivary gland for hyposalivation recovery. Pre-radiation therapy 
isolation of salivary gland stem or progenitor cells followed by 
post-radiation could increase the regenerative potential of the salivary 
gland and potentially completely restore tissue homeostasis following 
radiation therapy. To develop a cell-based therapy for hyposalivation, 
determining the most potent salivary gland stem or progenitor cell 
population, and further characterizing  of these cells,  and having 
ability to manipulate putative salivary gland stem or progenitor cells in 
vitro is paramount. 
2.2.4 Therapeutic use of primary culture with salivary gland 
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The first proof-of-concept study for transplanting autologous salivary 
gland cells to repair salivary function was carried out in a rodent 
model by transplantation of epithelial cells expressing KIT (c-Kit, 
CD117). In this study, about 100–300 KIT+ cells were enough to 
generate new acinar and ductal structures in damaged salivary glands 
and this treatment significantly improved organ function after radiation 
(Lombaert IM et al., 2008). This research demonstrated that KIT+ cells 
are possible mouse salivary gland stem cells, and then the 
transplantation of the KIT+ cells could restore the functions of salivary 
glands in mouse model. From several studies using transplantation of 
murine KIT+ sub-populations, it was demonstrated that KIT+ cells 
(KIT+ CD24+, KIT+ CD49f+, KIT+ CD24+ CD49f+, KIT+ CD24+ 
SCA+), has different levels of stem cell or progenitor activity, with 
KIT+ CD24+ (CD49f+/SCA+) cells reported to be the most potent 
(Nanduri LS et al., 2013; Xiao N et al., 2014). These cells are likely 
located within the major ducts of the central salivary gland region 
where the highest stem and progenitor cell number resides (van Luijk 
P et al., 2015). Thus, KIT+ cells could be potentially used for future 
cell therapy applications, because presence of KIT+ cells was proven in 
human salivary glands (Lombaert IM et al., 2013). and can be isolated 
and cultured ex vivo (Feng J et al., 2009). A very recent 
ground-breaking study has further supported the clinical use of enriched 
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KIT+ sub-populations. In this study, only 500 KIT+ salivary gland 
cells per gland were capable of rescuing hyposalivation in an in vivo
mouse model (Pringle S et al., 2016). 
In many studies, it has shown that restoration of function of 
irreversibly damaged mouse salivary glands after injection of in vitro
cultured cells presumably containing salivary gland stem cells is 
observed. These findings suggest the prospectiveness of clinical 
autologous salivary gland stem cell transplantation after radiotherapy. 
Another report demonstrated that injection of in vitro cultured cells 
into glands resulted in the remarkable morphological and functional 
restoring abilities over prolonged time intervals. (Lombaert IM et al., 
2008). Furthermore, repopulation of the original ductal compartment 
and differentiation of transplanted cells into acinar cells were observed 
as well in the same study (Lombaert IM et al., 2008). 
Most interestingly, repairing of salivary gland is not only driven by 
transplanted cells, but also by promoting the regenerative capacity of 
remaining endogenous stem or progenitor cells (Pringle S et al., 2016). 
Radiation can induce stem or progenitor cell awakening in vivo
(Lombaert IM et al., 2008; Hai B et al., 2012), and thus these stem 
cell population can be activated with appropriate stimuli. For example, 
any type of transplanted cells could enhance local endogenous repair 
when the appropriate stimuli are produced locally and a quiescence 
stem or progenitor cells are present nearby. However, clinically, this 
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approach may be limited to autologous cell therapy because salivary 
gland cells from aging patients contain fewer stem and progenitor cells 
(Feng J et al., 2009; Maimets M et al., 2015). This implies that more 
stem and progenitor cells (than those obtained in the pre-radiation 
therapy biopsy) may be required for organ repair. Recent efforts to 
increase the number of KIT1 cells ex vivo using growth factors (Patel 
VN et al., 2014) or Aldehyde dehydrogenase-3 (ALDH3) activator 
(Banh A et al., 2011) may be useful, however, the requirement of 
absolute cell number for functional regeneration in human remains 
unclear yet. These considerations may necessarily lead to find out more 
improved techniques in vitro culture system for enhancing the number 
of cells cultured.  
2.2.5 Limitations of salivary gland cell cultures
The development of a viable artificial salivary gland is a novel option 
in bringing relief to many patients afflicted with hyposalivation. Ideally, 
autologous primary cells should be used clinically (Hoekstra et al., 
2002). In cases of severely damaged or absent salivary glands, 
however, these individuals would need to depend on an artificial 
salivary gland grown from donor cells. Nevertheless, cells in primary 
cultures display slow growth, de-differentiation, and a finite lifespan 
(Redman et al., 1988; Yeh et al., 1991; Quissell et al., 1994a and 
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1994b).
Isabelle L et al have been reported that the difficulties in expansion of 
salivary gland stem cells in vitro for future clinical use (Isabelle L et 
al., 2017). Alternatively, transplantation of hematopoietic stem cell have 
been tried over the past 50 years, but the in vitro culture of 
hematopoietic stem cells is still challenging as well. (Wilson A et al., 
2006). Although a report has been shown that salivary gland cells can 
be cultured in vitro and produce saliva (Kishi T et al., 2007), this 
report could not suggest the culture capacity for application into a 
transplantable preclinical model without contamination of other 
potentially damage-inflicting cells. The recently demonstrated models 
may appear readily transplantable to the clinic and lead in the near 
future to clinical use of salivary gland tissue stem cells. Isabelle L et 
al propose the possibility that transplantation of these cells will result 
in amelioration of the significantly reduced quality of life of surviving 
cancer patients (Isabelle L et al., 2017). Furthermore, These approaches 
are the potential proof for the potential use of stem cell transplantation 
to functionally rescue solid organ deficiency and have now 
demonstrated that in vitro culture of processed salivary gland tissue is 
possible (Lombaert IM et al., 2008). Some studies have used a 
monolayer culture technique, where adherent, proliferative colonies of 
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presumed salivary gland cells, stem cells or progenitor cells were 
cultured from rat salivary glands, and after 7 days of culture with 
added epidermal growth factor and hepatocyte growth factor 
demonstrated expression of ductal (cytokeratins 18 and 19 and c-Met), 
acinar (amylase andaquaporin-5), and myoepithelial (vimentin and 
a-smooth muscle actin) differentiation marker proteins. Consequently, 
growing attention has been given to the improvement of salivary cell 
culture conditions in developing an artificial gland. 
2.3. ROCKi and its application
2.3.1. Roles of ROCK and ROCKi in biological systems
ROCKi, Y-27632, is an inhibitor of ROCK and was discovered as a 
downstream target of the small GTP-binding protein Rhos (Osailan SM 
et al., 2006). Previous studies showed that once Rho was activated by 
its activators, including sphingosine-1 phosphate and lysophosphatidic 
acid, Rho guanine nucleotide exchange factor (GEF) was stimulated 
and ROCK eventually modulates a wide spectrum of cellular events 
involving the actin cytoskeleton (Cotroneo E et al., 2010). It has been 
reported that ROCKi modulates cellular growth, migration, adhesion, 
apoptosis and metabolism by regulating the cytoskeletal assembly 
(Nedvetsky PI et al., 2014). Since ROCK mediates actomyosin 
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contraction, and activates apoptotic signaling cascades, ROCKi has been 
used in different biomedical purposes using cultured cells and tissues, 
and various animal models with multiple human diseases (Lombaert IM 
et al., 2013; Lu L et al., 2015).
Particularly, one of ROCKi, Y-27632, is quite stable in aqueous 
solution for a long time, it is widely used for in vitro culturing of 
cells or tissues at approximately 10 μM. By promoting focal adhesions 
and actomyosin contraction, it has been known that ROCKs regulate 
not only the migration, but also polarity of cells, suggesting the 
involvement of ROCKs in tumor metastasis (Bourguignon LY et al., 
1999). Indeed, a previous study showed that overexpression of activated 
ROCK promoted tumor invasion (Yoshioka K et al., 1999). Therefore, 
Y-27632 was previously used in vitro study that used different cancer 
cells or cell lines such as NIH 3T3 fibroblasts, Swiss 3T3 fibroblasts, 
and HeLa cells to investigate the role of Rho proteins in stress fiber 
formation, focal adhesion, and transformation. Y-27632 treatment in rat 
hepatoma cells and breast cancer cells reduced tumor-cell dissemination, 
suggesting its potential use in cancer therapy (Itoh K et al., 1999). 
In addition to cell lines, it was previously reported that Y-27632 
increased the survival rate of human keratinocytes cultured in vitro
(Chapman S et al., 2010). ROCKs also modulate the phagocytic 
activity of macrophages and the permeability of endothelial cells by 
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regulating actin cytoskeletal protrusions and tight and adherent junctions 
(Wojciak-Stothard B., 2001; Wojciak-Stothard et al., 2002). 
Additionally, ROCKs are involved in differentiation program of 
adipogenesis and myogenesis, and thus Y-27632 treatment in mice 
defecting RhoGAP restores normal adipogenesis (Sordella R et al., 
2003).
2.3.2. Apoptosis and ROCKi
A large body of recent evidence demonstrated that ROCK is involved 
in apoptotic and survival pathways in different types of cells. As 
described earlier, ROCK is involved in many morphological processes 
of apoptosis, including cell contraction, fragmentations of nucleus, 
membrane blebbing, and formation of apoptotic bodies (Orlando K et 
al., 2006). Previous studies showed that ROCKi treatments reduced 
apoptosis but others demonstrated that it promoted apoptosis (Svoboda, 
K et al., 2004). Overall, it is evident that ROCK plays key roles in 
both apoptosis and survival of cells  while the exact signaling 
pathways involved in ROCK remain to be elucidated. 
When adherent cells detached from ECM, cell membrane retracts and a 
series of morphological changes was occurred upon the onset of cell 
death, called apoptosis (Danial N et al., 2004). In the apoptotic 
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cascade, active caspase 3 cleaves and activates ROCK and the active 
form of the ROCK causes the membrane blebbing after cell 
detachment from ECM before nucleus condensation and fragmentation 
into apoptotic bodies (Coleman ML et al., 2001). Therefore, treatment 
with Y-27632 in apoptotic cells probably inhibit membrane blebbing 
and the related events in apoptotic program. However, other apoptotic 
events including caspase activation and release of cytochrome c from 
mitochondria still occurred in the presence of ROCKs (Coleman ML et 
al., 2001), suggesting that inhibiting ROCK by Y-27632 is not 
sufficient to allow cells escape cell death, but reduce a part of events 
in the apoptotic process. Thus the exact role of ROCK or ROCKi in 
the apoptotic program remains to be investigated.
2.3.3. ROCKi and in vitro expansion of cells
Human pluripotent stem cells (hPSCs) (human induced pluripotent stem, 
hiPSCs; and hESCs) have the potential to be an important source of a 
diverse cell type for basic research, clinical cell replacement therapies, 
and drug discovery and screening. However, culture and genetic 
manipulation of hPSCs are technically much difficult than mouse 
pluripotent stem cells due to their slow growth rate and anoikis, a 
programmed cell death of anchorage-dependent cells 
(dissociation-induced apoptosis) (Amit M et al., 2000). 
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Mouse pluripotent stem cells are able to grow as multiple-layered 
compact colonies when they were dissociated into single-cell suspension 
and plated in culture dishes as individual single cells. However, hPSCs 
grow as flat  monolayer colonies and most of the cells undergo 
apoptosis when the colony is disrupted by dissociation into single-cell 
suspensions (Watanabe K et al., 2007). The cell dissociation is the 
most common and inevitable procedure to manipulate cells in vitro for 
different purposes, including cell passaging, gene transfection, 
cyropreservation, purification using FACS (fluorescent activated cell 
sorting), and differentiation. Unfortunately, survival rate of single hPSC 
suspension was quite low due to anoikis (single-cell 
dissociation-induced apoptosis) of hPSCs. Therefore scientists have been 
performed only partial dissociation of hPSC colonies to make small 
cell clumps consisting of several cells, not as single cells, to maintain 
their survival (Leung et al., 1995). However, this attempts resulted in 
formation of heterogeneous sizes of clumps and colonies, contributing 
to the reduction in reproducibility of data obtained from studies. 
Therefore the dissociation-induced cell death was a major hurdle to 
overcome for efficient manipulation and maintenance of hPSC lines for 
stem cell research.
Recently, it was reported that ROCKi dramatically increased the 
survival of single-cell dissociated hPSCs (Watanabe K et al., 2007), 
suggesting that ROCKi promoted the survival of single-cell dissociated 
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hPSCs by perturbing apoptotic progress or increasing cell-cell 
interactions. ROCKi has now been widely used in the growth, freezing, 
gene transfer, and other manipulations of hPSCs and other cell types 
(Li X et al., 2008). For example, Y-27632 was used to increase cell 
recovery of sorted hPSCs after FACS (Emre et al., 2010). In addition, 
Y-27632 was useful for generating hiPSCs by enhancing survival of 
colonies after the gene delivery of reprogramming factors into cells 
(Park I et al., 2008). Y-27632 in culture mediums significantly 
enhanced the efficiency of hPSC colony formation after freezing and 
thawing (Li X et al., 2008). It has been reported that ROCKi was 
effective in culture of hPSCs in serum- and feeder-free culture 
conditions to avoid xenogeneic contaminations (Pakzad et al., 2010). 
Furthermore, Y-27632 also affects on differentiation of hPSCs, 
promoting formation of neural progenitors of specific regions of the 
brain (Osakada et al., 2009) and enhancing neurite outgrowth in neural 
stem cells by upregulating YAP expression (Jia XF et al., 2016). A 
recent study demonstrated that Y-27632 suppressed the expression of 
senescence-related proteins and significantly promoted cellular 
proliferation of progenitor cells and mesenchymal cells of the salivary 
gland in vitro (Nakamura K et al., 2013; Lee J et al., 2015).
Therefore, ROCKi, Y-27632, has been broadly used in different 
research areas in the cell culture studies, including expanding, freezing, 
differentiation, and gene delivery.
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3. Materials and methods
3.1 Preparation of primary submandibular salivary gland cells 
from mouse and in vitro culture
Submandibular gland tissues were harvested from 8-week-old C57/BL6 
mice (Raon bio co. Ltd., Korea). The tissues were dissociated from 
cervical fascia and connective tissues under a dissecting microscope 
and gently collected in phosphate-buffered saline (PBS; Welgene, 
Daegu, Korea). Freshly dissociated tissues were washed twice with 
Dulbecco’s modified Eagle’s medium and Ham’s F-12 mixture 
(DMEM/F12 medium, 1:1, Gibco, Grand Island, NY, USA) 
supplemented with 100 U/mL penicillin G and 100 mg streptomycin 
(Gibco), minced with ophthalmic curved scissors, and incubated with 
DMEM/F12 medium containing 4 mg/mL collagenase type IV 
(Sigma-Aldrich, St Louis, Mo) at 37°C for 30 min. Dissociated cells 
were centrifuged at 1,000 rpm for 1 min and washed twice with 
DMEM/F12 medium. The collected cell pellet was resuspended in 
DMEM/F12 medium and filtered through a 100 μm cell strainer (BD 
Falcon, Bedford, MA, USA). The purified cells were collected by 
centrifugation at 1,000 rpm for 5 min and the cell pellet was 
resuspended in the culture medium. The cells were plated at a density 
of 5 X 104cells/well in four-well plate in DMEM (Gibco) medium 
supplemented with 100 U/mL penicillin G and 100 mg streptomycin, 
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20 ng/mL epidermal growth factor (Sigma-Aldrich), 20ng/mL basic 
fibroblast growth factor (PeproTech, RockyHill, NJ, USA), 1/100N2 
supplement (Gibco), 10 mg  insulin-transferrin-selenium (Gibco), and 1 
mM dexamethasone (Sigma-Aldrich) with/without 10 mM ROCKi, 
Y-27632 (Calbiochem, Merck, Rockland, MA, USA) and incubated for 
24, 48, 72, and 96 h in 5% CO2at37°C. The plate was pretreated with 
20 mg Matrigel (BD Falcon) for 2 h before use. 
3.2 Measurement of the anti-apoptotic effect of Y-27632 on 
submandibular salivary gland cells
Analysis of the survival rate of submandibular salivary gland cells was 
performed in two different conditions. Two days after cell seeding, 
cells were treated with fresh medium with or without 10 mM Y-27632 
at different time points (24, 48, 72, and 96 h). The analysis of cell 
proliferation was performed by determining the kinetic values at each 
time point using a microscope (Nikon, Tokyo, Japan)
3.3 Cell proliferation assay
To confirm the proliferation of primary mouse salivary gland cells 
during in vitro culture at each time point (24, 48, 72, and 96 h), cells 
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were incubated with 10 mM 5-ethynyl-2'-deoxyuridine (EdU, Invitrogen, 
Grand Island, NY, USA) for 24h and their proliferation evaluated using 
Click-iT®EdU imaging Kit (Invitrogen), as per the manufacturer’s 
instructions. The nucleus was stained with 5mg/mL 4', 
6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) and cells were 
visualized under confocal laser scanning microscope (Carl Zeiss, 
Thornwood, NY, USA). 
3.4 In vitro live-dead assay
Cell viability assay was performed to study the effects of Y-27632 on 
the in vitro culture of primary mousesalivary gland cells using 
acetoxymethyl diacetyl ester of calcein-AM (Sigma-Aldrich) and 
propidium iodide (PI, Sigma-Aldrich). Cells were incubated with or 
without 10 mM Y-27632 in culture media for 24, 48, 72, and 96 h, 
followed by their treatment with 2 mM calcein-AM and 10 mM PI to 
differentiate between live and dead cells. The nucleus was stained with 
10 mM Hoechst 33342 (Invitrogen) and cells were visualized under a 
confocal laser scanning microscope.
3.5 In vitro scratch assay
31
After seeding in a six-well plate, cells were cultured in the medium 
supplemented with Y-27632, as mentioned above. Upon confluence, 
cells were washed twice with PBS and scratched using a 200 μL 
micropipette tip. The cells were washed with PBS and incubated in the 
medium with or without Y-27632. The results were observed every 5 
min until 24 h using a time-lapse live cell movie analyzer, JuLiTMBr 
(NanoEnTek Inc, Seoul, Korea) in three independent experiments, then, 
calculated the percentage of confluence and cell migration rate by the 
JuLiTMBr program.
3.6 Immunofluorescence staining 
Cells were fixed with cold 4% paraformaldehyde (Sigma-Aldrich) in 
PBS. After blocking and permeabilization in 0.3% Triton-X‑100 
(Sigma-Aldrich) and 10% donkey serum (Sigma-Aldrich) in 0.1% 
bovine serum albumin (Sigma-Aldrich)/PBS, the cells were overnight 
incubated at 4°C with primary antibodies, followed by 1 h incubation 
at room temperature with secondary antibodies. The primary antibodies 
used were anti-c-amylase (1:50, Santa Cruz Biotechnology) and 
anti-C-Met (1:200, Santa Cruz Biotechnology), while secondary 
antibodies included AlexaFluor 488 anti-mouse, 594 anti-mouse, and 
594 anti-rabbit (1:400, Invitrogen). Apotome-Axiovert 200M 
fluorescence microscope (Carl Zeiss) and confocal laser scanning 
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microscope (Carl Zeiss) were used to visualize cells after counter 
staining with 5 mg/mL DAPI.
3.7 Western blotting
Cells were harvested in a radio-immuno-precipitation assay (RIPA) lysis 
buffer  (Upstate, Charlottesville, VA, USA) supplemented with a 
cocktail tablet of protease inhibitors (Roche, Mannheim, Germany). 
Equal amounts of proteins (50 μg/lane) were electroporated on 
NuPageTM 4-12% Bis-Tris polyacrylamide gels (Invitrogen) and 
transferred onto polyvinylidene difluoride (PVDF) membranes 
(Invitrogen). The membranes were overnight incubated with various 
primary antibodies at4°C, followed by their treatment with secondary 
antibodies for 1.5 h at room temperature. The primary antibodies used 
were anti-C-Met (1:200, Santa Cruz Biotechnology) and anti-β-actin 
(1:50, Sigma-Aldrich), while the secondary antibodies used included 
donkey anti-mouse IgG-horseradish peroxidase (HRP; 1:10000, Santa 
Cruz Biotechnology), donkey anti-rabbit IgG-HRP (1:10000, Santa Cruz 
Biotechnology), and donkey anti-goat IgG-HRP (1:10000, Santa Cruz 
Biotechnology). The proteins were visualized with the enhanced 
chemiluminescence (ECL), Supersignal® West Pico Chemiluminescence 
substrate (Thermo, Prod #34077).
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3.8 Statistical analysis
All data were expressed as means ± SD from at least three 
independent experiments. Statistical differences of the two experimental 
groups (ROCKi+ and ROCKi-) were analyzed using Student's t-tests 
and P values less than 0.05 was considered statistically significant.
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4. Results
4.1 ROCKi treatment enhances the growth and survival of 
isolated submandibular gland cells
To test the effect of ROCK inhibition on the growth of salivary gland 
cells, the submandibular gland tissue was dissociated from mice and 
the isolated cells were cultured in the presence or absence of Y-27632. 
After 24 h, cells were attached to the surface of the plates both with 
or without Y-27632. However, the cell attachment was better in the 
presence of Y-27632; most attached cells showed three-dimensional 
aggregates in both conditions (Fig. 1a). After 48 h, a significant 
increase in the number of attached cells was observed in Y-27632 
treatment group and the cells started to spread out from the aggregates. 
Furthermore, the growth of cells dramatically increased following 
treatment with Y-27632 for 72 h and confluent cells were observed at 
96 h (Fig. 1a and c). In the absence of Y-27632, most cells 
maintained their aggregated states at 48 h and exhibited slow growth 
compared to Y-27632 treated cells (Fig. 1c); several acellular areas 
were observed at 96 h (Fig. 1a).
The live/dead cell population of cultured cells following their treatment 
with Y-27632 using fluorescence-based calcein-AM (green) and PI (red) 
staining was assessed. Although PI-positive dead cells (red) were 
observed at all time points, the number of dead cells was significantly 
reduced in the presence of Y-27632 (Fig. 1b and d). Therefore, these 
data indicate that ROCK inhibition enhances the survival and growth 
of primary cultured salivary gland cells.
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4.2 ROCK inhibition increases the proliferation of salivary 
gland cells
Following the observation of the increased survival and growth of 
salivary gland cells with ROCK inhibition, the proliferation of cultured 
cells with or without Y-27632 by EdU incorporation assay at 24, 48, 
72, and 96 h was assessed and the number of cells during the culture 
period was counted. The cell number greatly increased after 48 h 
culture with or without Y-27632 treatment; however, a six-fold increase 
in the cell number was observed following treatment with Y-27632 
from 48 to 72 h. On the contrary, only a three-fold increase in cell 
number was reported in the absence of Y-27632 at the same time 
point (Fig. 1c). Consistent with these observations, a significant 
increase in the number of proliferating cells was observed in the 
Y-27632 treatment group than in cells without inhibitor treatment (Fig. 
2a and b). Furthermore, EdU-positive proliferating cells exponentially 
increased in Y-27632 treatment group after 72 h and the numbers of 
EdU+ proliferating cells were about three-fold increased in Y-27632 
treated cells compared to control culture after 96 h (Fig. 2a and b). 
These data indicate that ROCK inhibition in the salivary gland cells 
may facilitate cell growth, as evident from the increase in cell 
proliferation.
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4.3 ROCK inhibition increases the motility of salivary gland 
cells
The effect of ROCK inhibition on the migration of salivary gland cells 
was assessed with the in vitro scratch assay. Images were obtained 
with JuLiTMBr live cell analyzer from 5 min to 24 h following 
treatment of cells with Y-27632 (Fig. 3). The time-lapse images at five 
time points (0, 4, 8, 10, and 23 h) after scratching showed that 
Y-27632 treatment increased the migration of salivary gland cells and 
the cell scratched over 90% confluency after 10 h (Fig. 3a). In the 
absence of Y-27632, the scratched area was slowly closed and the cell 
scratched confluency at 23 h (Fig. 3a). To confirm this morphological 
observation, a comparative analysis of the percentage confluency at 
different time points with an automated program was performed. Cells 
treated with Y-27632 reached confluency within averagely 13.5 h of 
treatment, whereas those without Y-27632 treatment took 23.5 h to 
reach confluency (Fig. 3b). Furthermore, the cell migration rate in the 
culture was assessed, then, Y-27632 treatment significantly increased 
cell migration rate of salivery gland cells (Fig. 3c). Thus, ROCK 
inhibition not only enhance the survival, growth, and proliferation of 
salivary gland cells but also increase their motility.
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4.4 ROCK inhibition induces the expression of salivary gland 
cell-specific markers
As hyposalivation causes reduction in the salivary flow rate, it is 
important to maintain the secretory functions of the in vitro cultured 
salivary gland cells. Thus, the expression of markers for acinar and 
ductal cells that play pivotal roles in the secretory functions of the 
salivary gland was assessed. The activities of antibodies against acinar 
cells (α-amylase) and ductal cells (C-Met) in the mouse salivary gland 
tissue were evaluated (Fig. 4a). Staining results showed that α-amylase 
was well stained in the cluster-structured acinar cells in the mouse 
tissue, while C-Met was stained well in the ductal structure of the 
mouse tissue (Fig. 4a).
To determine whether ROCK inhibition may induce the secretory 
function of the salivary gland under in vitro condition, salivary gland 
cells were cultured and analyzed the expression of markers at 72 and 
96 h (Fig. 4b-c). In the absence of Y-27632 treatment, the cultured 
cells showed the expression of α-amylase at 72 h but lost α-amylase 
expression at 96 h (Fig. 4b and c) and no C-Met expression was 
reported (Fig. 4b and c). On the contrary, Y-27632 treatment 
maintained the expression of α-amylase even at 96 h (Fig. 4b) and 
induced the expression of C-Met in salivary gland cells (Fig. 4b). The 
increase in the expression of ductal cell marker, C-Met, following 
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ROCK inhibition was also demonstrated by western blot analysis (Fig. 
4c). Therefore, ROCK inhibition in the salivary gland cells may result 
in the maintenance of the secretory function of the cells.
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5. Discussion
Hyposalivation as a consequence of curative radiotherapy in patients 
with head and neck cancer may reduce the function of salivary glands. 
As there is no effective therapy for hyposalivation, transplantation of 
primary cultured salivary gland cells has been considered as a 
therapeutic approach (Nelson J et al., 2013). However, acinar cells of 
the salivary gland easily lose their functions in in vitro cultures 
(Fujita-Yoshigaki J et al., 2009). Furthermore, these cells take a long 
time to reach confluency for their use in transplantation with the 
current methods of primary cell culture. 
The enzyme ROCK mediates various cellular functions related to cell 
morphology, motility, and survival. In this experiments, it was observed 
that the treatment of salivary gland cells with ROCKi resulted in an 
increase in the adhesion of cells onto the cell culture plate surface and 
enhanced their survival, growth, and proliferation. From these 
observations, it is suggested that the treatment of primary mouse 
submandibular gland cells with ROCKi may protect them from cell 
death during the initial attachment stage and in prolonged cultures. In 
addition, ROCK inhibition may offer advantages related to cell 
proliferation and growth in cultures. It was demonstrated that ROCK 
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inhibition in salivary gland cells may increase the migration of cells. 
Cell motility is an important factor for cell therapy. In the clinical 
application of MSCs, homing of the injected cells into the target tissue 
is a significant issue (De Becker A and Riet IV, 2016). Therefore, It 
is hypothesized that injection of cultured salivary gland cells in the 
presence of a ROCKi may provide better therapeutic applications 
through increased homing capacity of the cells.
In the presence of Y-27632, the cultured salivary gland cells exhibited 
prolonged expression of markers of acinar and ductal cells of the 
salivary gland. Primary salivary gland cells rapidly lose their secretory 
functions in vitro (Wigley CB and Franks LM, 1976). Furthermore, 
parotid acinar cells may change to duct-like cells during in vitro
epithelial-mesenchymal transition (Fujita-Yoshigaki J et al., 2009). 
However, it was found that the expression of α-amylase was retained 
in cells cultured in the presence of Y-27632. Furthermore, the inhibitor 
treatment also increased the expression of C-Met in salivary gland 
cells. Thus, ROCK inhibition in salivary gland cells may suppress the 
transition of acinar cells to ductal cells and amplify the number of 
ductal and acinar cells in the salivary cell culture. 
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6. Conclusion
In summary, this study demonstrates that ROCK inhibition may offer 
several advantages during the culture of primary salivary gland cells, 
such as increased cell survival, adhesion, growth and proliferation, 
migration, and cell type-specific marker expression. Therefore, it is 
concluded that ROCK inhibition in primary salivary gland cells may be 
used as a effective strategy for their easy and convenient application in 
clinical settings.
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Fig. 1 Survival and growth of salivary gland cells by ROCKi.
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Fig. 1 Survival and growth of salivary gland cells by ROCKi. (a) 
Representative morphological changes in isolated salivary gland cells 
during culture periods with or without Y-27632 treatment. (b) 
Calcein-AM/PI staining (live and dead cell assay) for isolated salivary 
gland cells during culture periods with or without Y-27632 treatment. 
R(+): cultured cells with Y-27632, R(−): cultured cells without Y-27632. 
(c) Number of isolated salivary gland cells during culture periods with 
or without Y-27632 treatment. (d) Numbers of PI-positive dying cells 
during culture periods with or without Y-27632 treatment. Scale bar = 
200 μm. *P < 0.05, **P < 0.01 versus R (-). 
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Fig. 2 Proliferation of salivary gland cells by ROCKi.
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Fig. 2 Proliferation of salivary gland cells by ROCKi. (a) EdU staining 
of isolated salivary gland cells cultured with or without Y-27632 
treatment. (b) Quantification of numbers of EdU-positive cells in (a). 
R(+): cultured cells with Y-27632 (n = 10 at each time point), R(−): 
cultured cells without Y-27632 (n = 10 at each time point). Scale bar 
= 200 μm. * P < 0.05 versus R(-).
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Fig. 3 Migration of salivary gland cells by ROCKi.
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Fig. 3 Migration of salivary gland cells by ROCKi. (a) Representative 
images from the scratch assay of isolated salivary gland cells with or 
without Y-27632 treatment (b and c). Comparison of average confluency 
rate and cell migration rate of isolated salivary gland cells, calculated 
with JuLiTMBr. R(+): cultured cells with Y-27632, R(−): cultured cells 
without Y-27632 treatment in three independent experiments. *P < 0.05
versus R(-). Scale bar = 200 μm.
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Fig. 4 Enhanced expression of salivary gland cell markers by ROCKi.
49
Fig. 4 Enhanced expression of salivary gland cell markers by ROCKi.
(a) Immunostaining of α-amylase and C-Met in rat salivary tissue. (b) 
Immunostaining of α-amylase and C-Met in isolated salivary gland cells 
with or without Y-27632 treatment. (c) Western blot analysis of C-Met 
expression in isolated salivary gland cells with or without Y-27632 
treatment. R(+): cultured cells with Y-27632, R(−): cultured cells 
without Y-27632 treatment. Scale bar = 50 μm.
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국문초록
방사선 치료를 받는 두경부 종양 환자들은 타액선 손상에 의한
타액분비저하로 부작용을 겪고 있다. 그러나 타액선 세포의 생체
외 배양시 낮은 생존율과 제한된 증식력은 세포 치료를 위한 충
분한 양의 타액선 세포를 획득하는데 걸림돌로 작용하고 있다.
Rho-associated kinase (ROCK)는 인간 줄기세포의 사멸을 저해함
과 동시에 생존율을 증가시키는 것으로 알려져 있으나, 타액선 세포
의 생체 외 배양에 미치는 영향은 크게 알려진 바 없다.
본 연구의 목적은 ROCK 억제제인 저분자 화합물, Y-27632이 타액
선 세포의 생체 외 배양에 미치는 영향을 조사 분석함으로써 타액
선 세포배양의 기술적 한계를 극복하기 위하여 실시되었다. 생존율,
사멸율, 증식율을 calcein-AM(생존세포 염색)/ propidium iodide(사
멸세포 염색), 5-ethynyl-2′-deoxyuridine (EdU)로 염색하여 검사
하였다. 세포증식과 이동능력 측정을 위해 in vitro scratch 분석을
시행하였고, 타액선 구성 세포의 표지 인자에 대한 세포면역형광염
색과 Western blot 을 수행하였다. 연구 결과 Y-27632 처리에 의한
ROCK의 활성 억제가 타액선 세포의 체외 증식을 위한 초기 배양
용기 부착 및 생착율, 배양 과정에서의 세포 성장과 이동 능력 뿐
만 아니라, 생체 외 배양기간 동안 타액선 선포세포와 관세포의 특
성유지를 모두 향상 시킬 수 있음이 확인되었다.
따라서 본 연구는 기존의 타액선 체세포의 배양에 따르는 기술적
한계를 극복하여 추후 타액선 세포치료에 적용할 수 있는 효과적인
방법을 제시하였다.
주요어 : ROCK 억제제, Y-27632, 타액분비저하, 악하선, 관세포, 초대세포
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